However, a strong TET signal from the Nidogen molecular beacon sometimes hampered the sensitivity of detection of approximately one spirochete

in the sample in multiplex systems (unpublished observation). This can be overcome by synthesizing molecular beacons with a combination of red (such as Texas red) and green (TET or FAM) fluorophore for use in multiplex analyses. This will be especially useful when the Combretastatin A4 supplier pathogen is present in very small numbers in the infected tissues. Simultaneous infection by several pathogens often creates difficulty in identifying the causative agent for a particular disease manifestation. Multiplex buy ARN-509 analysis using molecular beacons allows detection of a pathogen and the host tissue by PCR. Furthermore, additional pathogen(s) can be detected by including the appropriate molecular beacon in the assay. This is possible for up to seven molecular beacons,

each labeled with different fluorophores, which can be combined in one reaction to detect different amplicons, as long as PCR conditions are compatible. This is of great importance especially for the detection of multiple vector-borne bacterial illnesses in humans such as Lyme disease and human granulocytic anaplasmosis (HGA), caused by Anaplasma phagocytophila. Both Benzatropine of these organisms, along with several viruses, can be transmitted together to humans by Ixodes ticks, often complicating the diagnosis of Lyme disease. This study is focused on quantification specifically of B. burgdorferi,

and not other Lyme spirochetes, in the mouse tissues. We anticipate that in the future, after slight modifications of the primers and molecular beacon, we will be able to distinguish the presence of different Lyme see more spirochetes in clinical samples. An appropriate human gene region will also be selected for amplification and a specific molecular beacon designed for diagnostic purposes. In addition, we will be able to detect Lyme spirochetes in combination with other organisms in clinical samples after an infected tick bite using the specific primers and different fluorophore-tagged molecular beacons. This will help to identify the actual causative agent, facilitate proper treatment strategy and offer a better clinical outcome for the patient. Furthermore, it will be possible to adapt this system to detect microbes in other systems, such as in the infected plants.